4.6 Article

Association of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries

Journal

JAMA CARDIOLOGY
Volume 7, Issue 8, Pages 796-807

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamacardio.2022.1581

Keywords

-

Funding

  1. Population Health Research Institute, Hamilton Health Sciences Research Institute
  2. Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario
  3. Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit
  4. Ontario Ministry of Health and Long-Term Care
  5. AstraZeneca (Canada)
  6. Sanofi-Aventis (France)
  7. Sanofi-Aventis (Canada)
  8. Boehringer Ingelheim (Germany)
  9. Boehringer Ingelheim (Canada)
  10. Servier
  11. GlaxoSmithKline
  12. Novartis and King Pharma
  13. various national or local organizations in participating countries, which include Fundacion ECLA (Estudios Clinicos Latino America
  14. Argentina)
  15. Independent University and Mitra and Associates (Bangladesh)
  16. Unilever Health Institute (Brazil)
  17. Public Health Agency of Canada, Champlain Cardiovascular Disease Prevention Network (Canada)
  18. International Development Research Centre (Canada)
  19. Universidad de la Frontera (Chile)
  20. National Center for Cardiovascular Diseases (China) [NCRC2020002]
  21. Colciencias (Colombia) [6566-04-18062]
  22. Indian Council of Medical Research (India)
  23. Ministry of Science, Technology, and Innovation of Malaysia [100-IRDC/BIOTEK 16/6/21 [13/2007], 07-05-IFN-BPH 010]
  24. Ministry of Higher Education of Malaysia [600-RMI/LRGS/5/3 [2/2011]]
  25. Universiti Teknologi MARA, Universiti Kebangsaan Malaysia [15-2010]
  26. United Nations Relief andWorks Agency for Palestine Refugees in the Near East (occupied Palestinian territory)
  27. Philippine Council for Health Research and Development (Philippines)
  28. Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]
  29. Wroclaw Medical University (Poland)
  30. Saudi Heart Association, Dr Mohammad Alfagih Hospital
  31. Deanship of Scientific Research at King Saud University [RG-1436-013]
  32. Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University, Makkah (Saudi Arabia)
  33. North-West University and Netherlands Programme for Alternative Development, National Research Foundation
  34. Medical Research Council of South Africa
  35. South Africa Sugar Association, Faculty of Community and Health Sciences (South Africa)
  36. Swedish state under the agreement concerning research and education of doctors
  37. Swedish Heart and Lung Foundation
  38. Swedish Research Council
  39. Swedish Council for Health (Sweden)
  40. Working Life andWelfare (Sweden)
  41. King Gustaf V's and Queen Victoria Freemason's Foundation (Sweden)
  42. AFA Insurance (Sweden)
  43. Metabolic Syndrome Society, AstraZeneca, Sanofi-Aventis (Turkey)
  44. Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences (United Arab Emirates)
  45. Dubai Health Authority (United Arab Emirates)

Ask authors/readers for more resources

Sitting for long periods of time is associated with increased risks of cardiovascular disease and mortality, especially in low- and middle-income countries. Reducing sedentary time and increasing physical activity may be an important strategy to reduce the global burden of premature deaths and cardiovascular disease.
IMPORTANCE High amounts of sitting time are associated with increased risks of cardiovascular disease (CVD) and mortality in high-income countries, but it is unknown whether risks also increase in low- and middle-income countries. OBJECTIVE To investigate the association of sitting time with mortality and major CVD in countries at different economic levels using data from the Prospective Urban Rural Epidemiology study. DESIGN, SETTING, AND PARTICIPANTS This population-based cohort study included participants aged 35 to 70 years recruited from January 1, 2003, and followed up until August 31, 2021, in 21 high-income, middle-income, and low-income countries with a median follow-up of 11.1 years. EXPOSURES Daily sitting time measured using the International Physical Activity Questionnaire. MAIN OUTCOMES AND MEASURES The composite of all-cause mortality and major CVD (defined as cardiovascular death, myocardial infarction, stroke, or heart failure). RESULTS Of 105 677 participants, 61 925 (58.6%) were women, and the mean (SD) age was 50.4 (9.6) years. During a median follow-up of 11.1 (IQR, 8.6-12.2) years, 6233 deaths and 5696 major cardiovascular events (2349 myocardial infarctions, 2966 strokes, 671 heart failure, and 1792 cardiovascular deaths) were documented. Compared with the reference group (<4 hours per day of sitting), higher sitting time (>= 8 hours per day) was associated with an increased risk of the composite outcome (hazard ratio [HR], 1.19; 95% CI, 1.11-1.28; P for trend < .001), all-cause mortality (HR, 1.20; 95% Cl. 1.10-1.31; P for trend < .001), and major CVD (HR, 1.21; 95% CI, 1.10-1.34; P for trend < .001). When stratified by country income levels, the association of sitting time with the composite outcome was stronger in low-income and lower-middle-income countries (>= 8 hours per day: HR, 1.29; 95% CI, 1.16-1.44) compared with high-income and upper-middle-income countries (HR, 1.08; 95% CI, 0.98-1.19; P for interaction = .02). Compared with those who reported sitting time less than 4 hours per day and high physical activity level, participants who sat for 8 or more hours per day experienced a 17% to 50% higher associated risk of the composite outcome across physical activity levels; and the risk was attenuated along with increased physical activity levels. CONCLUSIONS AND RELEVANCE High amounts of sitting time were associated with increased risk of all-cause mortality and CVD in economically diverse settings, especially in low-income and lower-middle-income countries. Reducing sedentary time along with increasing physical activity might be an important strategy for easing the global burden of premature deaths and CVD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available